Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2000 - Compounding for Hospice and Cancer Patients
View All Articles in Issue

Abstract:  A formulation for preparing Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Categories: CANCER AND AIDS, FORMULATIONS, STABILITIES, COMPATIBILITIES

Printer-Friendly Version